Brad L. Tade

CIK: 0002030561

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (16.7%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (16.7%)

Compensation grants

Other (G, F, J, C, D, …)4 (66.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ADMA

ADMA BIOLOGICS, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

ADMA
ADMA BIOLOGICS, INC.
Feb 19, 2026
Tax Payment(F)
Direct
6.5K shares at avg. $16.32$106K
ADMA
ADMA BIOLOGICS, INC.
Jul 24, 2025
Tax Payment(F)
Direct
7.1K shares at avg. $17.31$123K
ADMA
ADMA BIOLOGICS, INC.
Jun 26, 2025
Tax Payment(F)
Direct
9.8K shares at avg. $18.40$181K
ADMA
ADMA BIOLOGICS, INC.
Feb 26, 2025
Tax Payment(F)
Direct
5.3K shares at avg. $15.78$83K
ADMA
ADMA BIOLOGICS, INC.
Feb 19, 2025
Award(A)
Direct
62.2K shares-
ADMA
ADMA BIOLOGICS, INC.
Nov 22, 2024
Sale(S)
Direct
15K shares at avg. $21.15$317K

		Type	Shares	Price		Ownership
Feb 19, 2026	ADMA ADMA BIOLOGICS, INC.	Tax Payment(F)	6,479	$16.32	$105,737	Direct
Jul 24, 2025	ADMA ADMA BIOLOGICS, INC.	Tax Payment(F)	7,123	$17.31	$123,299	Direct
Jun 26, 2025	ADMA ADMA BIOLOGICS, INC.	Tax Payment(F)	9,838	$18.40	$181,019	Direct
Feb 26, 2025	ADMA ADMA BIOLOGICS, INC.	Tax Payment(F)	5,280	$15.78	$83,318	Direct
Feb 19, 2025	ADMA ADMA BIOLOGICS, INC.	Award(A)	62,227	-	-	Direct
Nov 22, 2024	ADMA ADMA BIOLOGICS, INC.	Sale(S)	15,000	$21.15	$317,250	Direct

1-6 of 6 transactions

About Tade Brad L.

Tade Brad L. (SEC CIK 0002030561) files insider reports with the SEC as CFO and Treasurer of ADMA BIOLOGICS, INC. (ADMA).

Signal8 holds 6 ownership filings by Tade Brad L., all Form 4s, filed between Nov 22, 2024 and Feb 23, 2026. Those filings report 6 transactions, from Nov 22, 2024 to Feb 19, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Tade Brad L.'s filings is in BOCA RATON, FL.

Recent filings by Tade Brad L.

Feb 19, 2026: Tax withholding of ADMA shares (Form 4, code F).
Jul 24, 2025: Tax withholding of ADMA shares (Form 4, code F).
Jun 26, 2025: Tax withholding of ADMA shares (Form 4, code F).
Feb 26, 2025: Tax withholding of ADMA shares (Form 4, code F).
Feb 19, 2025: Grant or award of ADMA shares (Form 4, code A).

Other insiders filing for ADMA BIOLOGICS, INC. (ADMA)

Kestenberg-Messina Kaitlin M., COO and SVP, Compliance
Kohler Terry, CFO and Treasurer
Grossman Jerrold B, Director
Guiheen Lawrence P., Director
Grossman Adam S, President and CEO
ELMS STEVE, Director

How to read Form 4 transaction codes